Harmony Biosciences Appoints Peter Anastasiou as New CEO
Harmony Biosciences (HRMY) announced the appointment of Peter Anastasiou as its new President, Chief Executive Officer, and member of the Board of Directors. The transition is set to take effect on January 1, 2027. Anastasiou will succeed Jeffrey Dayno, who has decided to retire from his roles at the company. The leadership change marks a strategic shift for Harmony Biosciences as it prepares for future growth and operational direction under new management. The board expressed confidence in Anastasiou's ability to lead the organization forward following an extensive search process.
Tickers: $HRMY
Topics: Leadership Management Transition